3 As neuroscientist Elie Gottlieb, PhD, who was not involved in the study, notes, Where this study adds the most value is in reminding the field that a treatment strategy anchored exclusively to weight losswhether through GLP-1 receptor agonists, bariatric surgery, or lifestyle interventionwill leave a substantial portion of the OSA population without a clear therapeutic path.' This is where a new opportunity lies
Some of the potential risks and challenges associated with PPR are outlined in Table 2 and Figure 2
These reductions were accompanied by significant body weight loss, confirming a robust pharmacodynamic response
2012 May;1822(5):625-30
Setria Glutathione Earns First Registered Finished Product in Chile Through SEREMI de Salud News provided by Kyowa Hakko U.S.A Jun 11, 2026, 08:00 ET Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud
Experience the next generation of metabolic support
